Kevin Caliendo
Stock Analyst at UBS
(4.48)
# 270
Out of 4,876 analysts
183
Total ratings
70.45%
Success rate
11.64%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $400 → $385 | $305.69 | +25.94% | 12 | Jun 25, 2025 | |
| LFST LifeStance Health Group | Upgrades: Buy | $8.5 | $5.15 | +65.05% | 4 | May 27, 2025 | |
| ZIMV ZimVie | Maintains: Neutral | $16 → $10 | $9.07 | +10.25% | 1 | May 15, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $6 → $5.25 | $4.97 | +5.63% | 4 | May 13, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $27 → $25 | $15.89 | +57.33% | 10 | May 9, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $15 | $10.81 | +38.82% | 3 | May 9, 2025 | |
| AMWL American Well | Maintains: Neutral | $12 → $9 | $7.81 | +15.30% | 3 | May 8, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $21 → $18 | $19.65 | -8.40% | 3 | May 5, 2025 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $16 → $17 | $13.74 | +23.73% | 7 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $160 → $170 | $167.02 | +1.78% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $71 | $68.43 | +3.76% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $708 → $805 | $727.68 | +10.63% | 14 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $298.16 | +12.36% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $188.36 | +14.14% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $83 → $80 | $73.42 | +8.96% | 5 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $13 | $8.41 | +54.58% | 5 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $330 → $305 | $293.69 | +3.85% | 3 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $329.70 | +18.29% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $166 → $170 | $178.79 | -4.92% | 13 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $293 → $286 | $260.59 | +9.75% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $11.45 | -12.63% | 14 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $240.28 | +4.05% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $53.76 | +46.95% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $21.75 | +19.54% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $376.68 | +52.65% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $152.54 | +18.00% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $8.62 | +735.27% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $16.81 | -34.56% | 4 | May 4, 2021 |
UnitedHealth Group
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $305.69
Upside: +25.94%
LifeStance Health Group
May 27, 2025
Upgrades: Buy
Price Target: $8.5
Current: $5.15
Upside: +65.05%
ZimVie
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $9.07
Upside: +10.25%
GoodRx Holdings
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $4.97
Upside: +5.63%
DENTSPLY SIRONA
May 9, 2025
Maintains: Buy
Price Target: $27 → $25
Current: $15.89
Upside: +57.33%
Evolent Health
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $10.81
Upside: +38.82%
American Well
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $7.81
Upside: +15.30%
Envista Holdings
May 5, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $19.65
Upside: -8.40%
Alignment Healthcare
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $13.74
Upside: +23.73%
Cardinal Health
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $167.02
Upside: +1.78%
May 2, 2025
Maintains: Neutral
Price Target: $67 → $71
Current: $68.43
Upside: +3.76%
Apr 29, 2025
Maintains: Buy
Price Target: $708 → $805
Current: $727.68
Upside: +10.63%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $298.16
Upside: +12.36%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $188.36
Upside: +14.14%
Feb 26, 2025
Maintains: Neutral
Price Target: $83 → $80
Current: $73.42
Upside: +8.96%
Feb 13, 2025
Maintains: Buy
Price Target: $25 → $13
Current: $8.41
Upside: +54.58%
Feb 7, 2025
Maintains: Neutral
Price Target: $330 → $305
Current: $293.69
Upside: +3.85%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $329.70
Upside: +18.29%
Feb 3, 2025
Maintains: Neutral
Price Target: $166 → $170
Current: $178.79
Upside: -4.92%
Jan 28, 2025
Maintains: Buy
Price Target: $293 → $286
Current: $260.59
Upside: +9.75%
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $11.45
Upside: -12.63%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $240.28
Upside: +4.05%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $53.76
Upside: +46.95%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $21.75
Upside: +19.54%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $376.68
Upside: +52.65%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $152.54
Upside: +18.00%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $8.62
Upside: +735.27%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $16.81
Upside: -34.56%